Mavacoxib (trade name Trocoxil) is a veterinary drug used to treat pain and inflammation in dogs with degenerative joint disease.[1] It acts as a COX-2 inhibitor.[2]
Clinical data | |
---|---|
Trade names | Trocoxil |
AHFS/Drugs.com | International Drug Names |
ATCvet code |
|
Identifiers | |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.248.948 |
Chemical and physical data | |
Formula | C16H11F4N3O2S |
Molar mass | 385.34 g·mol−1 |
3D model (JSmol) |
|
| |
|
Mavacoxib, along with other COX-2 selective inhibitors, celecoxib, valdecoxib, and parecoxib, were discovered by a team at the Searle division of Monsanto led by John Talley.[3][4]